| SC 13D/A | 2024-02-15 | Starboard Value LP | ACACIA RESEARCH CORP | 61,123,595 | 61.2% | EDGAR |
| SC 13D/A | 2023-07-17 | Starboard Value LP | ACACIA RESEARCH CORP | 61,123,595 | 61.2% | EDGAR |
| SC 13D/A | 2023-03-03 | Starboard Value LP | ACACIA RESEARCH CORP | 20,000,000 | 34.2% | EDGAR |
| SC 13G/A | 2023-02-08 | Invesco Ltd. | ACACIA RESEARCH CORP | 87,331 | 0.2% | EDGAR |
| SC 13D | 2022-11-08 | Starboard Value LP | ACACIA RESEARCH CORP | 5,000,000 | 11.5% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | ACACIA RESEARCH CORP | 944,419 | 2.1% | EDGAR |
| SC 13D/A | 2022-06-29 | ACACIA RESEARCH CORP | Spok Holdings, Inc | 966,883 | - | EDGAR |
| SC 13G/A | 2022-02-10 | RENAISSANCE TECHNOLOGIES LLC | ACACIA RESEARCH CORP | 2,036,500 | 4.1% | EDGAR |
| SC 13G/A | 2022-02-09 | Invesco Ltd. | ACACIA RESEARCH CORP | 2,591,409 | 5.2% | EDGAR |
| SC 13G/A | 2022-02-01 | BlackRock Inc. | ACACIA RESEARCH CORP | 3,371,746 | 6.8% | EDGAR |
| SC 13D | 2021-08-30 | ACACIA RESEARCH CORP | Spok Holdings, Inc | 1,261,883 | - | EDGAR |
| SC 13G/A | 2021-06-24 | Parian Global Management LP | ACACIA RESEARCH CORP | 0 | 0.0% | EDGAR |
| SC 13G | 2021-02-18 | Parian Global Management LP | ACACIA RESEARCH CORP | 3,637,476 | 7.2% | EDGAR |
| SC 13G | 2021-02-16 | Invesco Ltd. | ACACIA RESEARCH CORP | 2,555,321 | 5.2% | EDGAR |
| SC 13G/A | 2021-02-11 | RENAISSANCE TECHNOLOGIES LLC | ACACIA RESEARCH CORP | 2,820,300 | 5.7% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | ACACIA RESEARCH CORP | 2,075,549 | 4.2% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | ACACIA RESEARCH CORP | 2,542,310 | 5.2% | EDGAR |
| SC 13G | 2020-06-11 | ACACIA RESEARCH CORP | Theravance Biopharma, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2020-06-09 | ACACIA RESEARCH CORP | Evofem Biosciences, Inc. | 1,000 | 0.0% | EDGAR |
| SC 13D/A | 2020-03-10 | ACACIA RESEARCH CORP | Veritone, Inc. | 1,120,432 | 4.4% | EDGAR |